American Association for the Study of Liver Diseases

What it reported doing in 2024

Publications: aasld's journals, hepatology, liver transplantation, and hepatology communications deliver peer-reviewed, high-impact research on liver and biliary tract diseases, setting the standard for scientific excellence in the field. Aasld's flagship journal, hepatology, publishes original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished editorial board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism. Liver transplantation publishes cutting edge scientific breaktrliver transplantation, a specialized journal, provides authoritative insights into the latest advancements in liver transplantation. Hepatology communications, an open-access, peer-reviewed journal, ensures rapid dissemination of high-quality basic, translational, and clinical research, amplifying aasld's commitment to advancing hepatology worldwide.professional relations: aasld's professional relations initiatives strengthen the hepatology community through:1. Aasld practice guidelines: evidence-based recommendations grounded in rigorous scientific research to guide practitioners and patients in making informed healthcare decisions for specific clinical scenarios.2. Practice metrics committee: this committee develops and refines performance measures to evaluate and enhance the quality of care for liver disease patients from both provider and patient perspectives. It drives quality improvement initiatives, such as the cirrhosis quality collaborative (cqc), and collaborates with other aasld committees and specialty societies to advance patient safety and care standards.3. Related society collaborations: aasld fosters partnerships with domestic and international medical societies to advance hepatology through shared programs and activities. Member representatives advocate for aasld's mission at global meetings, creating programs that resonate with audiences interested in mutual topics.4. Patient engagement: aasld is dedicated to deepening patient connections by increasing patient representation in its activities, enhancing access to expert resources, and building robust advocacy partnerships to amplify the patient voice in hepatology.clinical and public policy: aasld's public policy committee leads a robust advocacy program, hosting two key annual events: - liver capitol hill day: in partnership with patient advocacy organizations, aasld educates congressional legislators and staff on critical issues in liver disease research and patient care, driving policy change.- federal agency day: aasld engages with federal agency partners to align the scientific community with federal research priorities, fostering collaboration and innovation.aasld ensures its members stay informed on legislative and agency decisions impacting hepatology, encouraging active participation in public policy advocacy.

Financial Efficiency

• Mission deployment rate: 98.5%; rating input score 98
• Program expense ratio: 87.7%; rating input score 88
• Fundraising efficiency: $180.55 raised per $1 spent on fundraising; rating input score 89; 89th percentile among comparable filings

Transparency & Controls

• Consistency checks: 93.8%; rating input score 94; 17th percentile among comparable filings
• Pay-setting controls: 4 of 6 controls in place; rating input score 67
  • Compensation committee: Missing
  • Independent consultant: Pass
  • Other Form 990s reviewed: Pass
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Limited
• Grant itemization coverage: 91.3%; rating input score 91; 21st percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Yes; rating input score 100

Accountability

• Independent voting board: 100%; rating input score 100; 66th percentile among comparable filings
• Governance controls: 8 of 9 controls in place; rating input score 89
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Fail
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: -11.1%; rating input score 9; 9th percentile among comparable filings
• Total-asset coverage ratio: 1.73; rating input score 56; 56th percentile among comparable filings
• Liabilities to assets ratio: 0.2; rating input score 59; 59th percentile among comparable filings
• Officer compensation ratio: 13.6%; rating input score 11; 11th percentile among comparable filings

Growth

• Program expense growth: 3.6% per year; rating input score 100; 31st percentile among comparable filings
• Revenue growth: 1.4% per year; rating input score 100; 14th percentile among comparable filings
• Asset growth: -2.7% per year; rating input score 0; 5th percentile among comparable filings